Nurix Therapeutics stock price
누릭스 테라퓨틱스NASDAQ:NRIX · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →Nurix Therapeutics last closed at $22.99 (-1.50%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -7.5×. Its overall grade ranks 536 of 739 stocks in Healthcare.
About this company
Nurix Therapeutics last closed at $22.99 (-1.50%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C · 536/739
Valuation grade B-
Related stocks
- SanofiCustomer
Nurix의 BTK 분해제 등 파이프라인에 대한 전략적 협업·개발 파트너
- Gilead SciencesCustomer
Nurix의 면역학/종양학 파이프라인에 대한 협업 파트너
- GSKCustomer
Nurix의 단백질 분해 기술 기반 공동연구·라이선스 협업 파트너
ETFs holding this stock
iShares Micro-Cap ETF
Details →About Nurix Therapeutics
- What technical signals does Nurix Therapeutics (NRIX) have?
- Nurix Therapeutics current technical signals: no active technical signal.
- Is Nurix Therapeutics a cup-and-handle pattern?
- No. Nurix Therapeutics has no valid Cup signal right now.
- What published figures are available for Nurix Therapeutics?
- Market cap: $2.33B. Trailing 12 months PER: -7.5×. Latest quarter PBR: 6.34×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Nurix Therapeutics, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).